Diabetes/metabolism research and reviews
The most recent articles from:
September 2009
-
Diabetes Metab. Res. Rev. · Sep 2009
Randomized Controlled Trial Multicenter Study Clinical TrialEffects of therapy in type 1 and type 2 diabetes mellitus with a peptide derived from islet neogenesis associated protein (INGAP).
Islet neogenesis associated protein (INGAP) has beta cell regenerating effects in experimental models. ⋯ INGAP peptide increases C-peptide secretion in T1DM and improves glycaemic control in T2DM. Longer-term exposure, more frequent dosing, better tolerated formulations or combination with other therapies may be necessary to achieve optimal clinical response.